The sequential decline in operating margin from 12.3% in 2025Q3 to 8.6% in 2026Q2, despite relatively stable gross margins around 31-33%, indicates that SG&A and other operating expenses are growing faster than revenue. This trend aligns with the prior income statement analysis showing SG&A up 14.1% YoY versus revenue growth of only 5.3%. The net margin of 5.8% in 2026Q2 is the lowest in the reported period, down from 8.8% in 2024Q2, which may reflect a combination of higher talent costs and a shift in engagement mix toward lower-margin work. Investors should monitor whether management can pass on cost increases through higher billable rates, as a sustained compression would suggest a structural margin reset.

ROIC has been on a downward trajectory, from 3.6% in 2024Q1 to 2.6% in 2026Q2, even as the company increased leverage significantly. The rise in debt to fund share repurchases has expanded the capital base without a corresponding increase in operating income, leading to a lower return on invested capital. ROE also declined from 4.0% in 2024Q1 to 3.9% in 2026Q2, but this masks the impact of a shrinking equity base due to buybacks. The combination of rising leverage and falling returns suggests that capital allocation decisions may be destroying value, as the cost of debt likely exceeds the incremental returns generated. This trend warrants close monitoring, as continued buybacks without operational improvement could further erode shareholder value.

Days sales outstanding have remained elevated in the 109-122 day range over the past ten quarters, reflecting the protracted nature of litigation and restructuring engagements where milestone payments are common. The slight increase in DSO to 114 days in 2026Q2, combined with the extreme quarterly swings in operating cash flow (from -$310M in 2026Q1 to +$152M in 2026Q2), suggests that cash collection timing is a significant source of volatility. The absence of inventory data is consistent with a services business, but the high DSO indicates that FCN extends substantial credit to clients, which may tie up cash and increase credit risk. Investors should monitor whether DSO trends upward further, as that could signal deteriorating collection efficiency or a shift toward clients with weaker payment profiles.

The company's debt levels have surged from $242.1M in 2024Q4 to $1.3B in 2026Q2, funded largely to support aggressive share repurchases. This has driven D/E from 0.11 to 0.95, and D/EBITDA from 2.46 to 14.81, a dramatic increase that suggests the balance sheet is now significantly more leveraged. Interest coverage has correspondingly fallen from 84.24x in 2025Q1 to 7.36x in 2026Q2, which, while still adequate, indicates a much thinner cushion for debt service. The rapid pace of leverage accumulation, combined with the recent EPS miss and margin pressure, raises concerns about the sustainability of the capital return program. If operating performance continues to deteriorate, the company may face refinancing risk or be forced to curtail buybacks, which could impact shareholder returns.

While the current ratio of 2.03 and quick ratio of 2.03 suggest adequate short-term liquidity, the absolute cash balance has declined sharply, from $660.5M in 2024Q4 to $163.7M in 2026Q2. This reduction in cash, combined with the increase in debt, means the company has less flexibility to absorb unexpected downturns or fund working capital needs. The high DSO and volatile cash flows from litigation and restructuring engagements further underscore the importance of maintaining a strong liquidity buffer. Although the current ratio remains above 2.0, the trend is concerning, and investors should monitor whether cash levels stabilize or continue to decline, as that could signal a need for additional debt or a reduction in capital returns.